Application of Individualized Bayesian Urea Kinetic Modeling to pediatric hemodialysis

Olivera Marsenic1, Liping Zhang, Athena Zuppa

  • 1Laboratory for Applied PK/PD, Division of Clinical Pharmacology and Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. oljamc@mac.com

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|February 20, 2010
PubMed

Insights

An Individualized Bayesian Urea Kinetic Model (IBKM) accurately predicts equilibrated urea concentration (Ceq) in pediatric hemodialysis (HD) patients. This model uses pre-HD and post-HD blood urea nitrogen (BUN) levels, simplifying Ceq assessment in children.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Biomedical Engineering

Background:

  • Accurate assessment of hemodialysis (HD) efficiency requires incorporating urea rebound via equilibrated urea concentration (Ceq).
  • Measuring Ceq clinically is impractical, and no reliable methods exist for predicting Ceq in pediatric patients.
  • The Individualized Bayesian Urea Kinetic Model (IBKM) was developed using adult data to estimate individual Ceq.

Purpose of the Study:

  • To assess the efficacy of the IBKM in predicting Ceq in children undergoing HD.
  • To validate the IBKM's predictive capabilities using clinical data from pediatric HD sessions.

Main Methods:

  • A two-pool urea kinetic model (IBKM) was applied to blood urea nitrogen (BUN) samples from 30 HD sessions in 13 children (ages 12-18).
  • BUN samples were collected pre-HD, immediately post-HD, and 60 minutes post-HD (to measure observed Ceq).
  • The IBKM, using population parameters from adult data, was fitted to observed pediatric data using NONMEM VI software.

Main Results:

  • The IBKM accurately predicted individual Ceq in children, with an average predicted Ceq of 9.4 +/- 3.8 mmol/L compared to an observed Ceq of 9.5 +/- 3.8 mmol/L.
  • The absolute individual prediction error was low at 6.2% +/- 4.4%.
  • The IBKM also predicted necessary blood flow rate and dialyzer size for achieving dialysis goals.

Conclusions:

  • The IBKM is a viable tool for predicting Ceq in pediatric hemodialysis settings.
  • The model accurately predicts Ceq in children using readily available pre-HD and post-HD BUN measurements.
  • This facilitates more precise assessment of HD efficiency in pediatric patients.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a drug,...